Intesa Sanpaolo Wealth Management

Position in MRNA — Moderna, Inc.

CIK 2110902 LUXEMBOURG, N4

Position in MRNA

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$353,931

+$97,188 QoQ

Shares Held

5,054

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.08%

of 13F equity value

Holder Rank

#415

of 772 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Intesa Sanpaolo Wealth Management holds $418,945 across 5 Biotechnology names. MRNA ranks #1 (84.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc. This page	5,054	$353,931
2	NRIX	Nurix Therapeutics, Inc.	1,610	$39,058
3	LEGN	Legend Biotech Corp	815	$23,537
4	BNTX	BioNTech SE	26	$2,419
5	AIM	AIM ImmunoTech Inc.	1	$0

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$353,931	5,054	0.0%	Shares	Defined	2026-07-23
2026-03-31	$256,743	5,054	-2.3%	Shares	Defined	2026-05-15
2025-12-31	$152,581	5,174	—	Shares	Defined	2026-02-12
No filing history on record for this holder in this stock.